Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8727070 | 0.84 | PTPN1 (0.55) | SLC6A4TAAR1SLC6A2ADRB2ADRB3 | |
| SCHEMBL8727063 | 0.84 | PTPN1 (0.55) | SLC6A4TAAR1SLC6A2ADRB2ADRB3 | |
| SCHEMBL8636517 | 0.83 | SLC6A4 (0.50) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL8986923 | 0.81 | SLC6A4 (0.47) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL8634785 | 0.78 | SLC6A4 (0.47) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL8634781 | 0.78 | SLC6A4 (0.47) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL8634784 | 0.78 | SLC6A4 (0.47) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL9062874 | 0.77 | SLC6A4 (0.50) | SLC6A4TAAR1SLC6A2 | |
| SCHEMBL8758035 | 0.77 | ADRB3 (0.48) | SLC6A4TAAR1SLC6A2ADRB3 | |
| SCHEMBL8732233 | 0.77 | ADRB3 (0.48) | SLC6A4TAAR1SLC6A2ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0717746-A1 | PHOSPHINIC ACID DERIVATIVES WITH ANTI-HYPER GLYCEMIC AND/OR ANTI-OBESITY ACTIVITY | SMITHKLINE BEECHAM PLC (GB) | 1996-06-26 | — | — | EP | disclosed |
| WO-1995007284-A1 | PHOSPHINIC ACID DERIVATIVES WITH ANTI-HYPER GLYCEMIC AND/OR ANTI-OBESITY ACTIVITY | SMITHKLINE BEECHAM PLC (GB) | 1995-03-16 | — | — | WO | disclosed |